TNFRSF8 and lymphoma: It has been already reported by Menzel et al (2008) on a powerful anti-CD30 scFv-Fc-RNase, made up of a CD30 lymphoma specific human scFv-Fc fused to HP-RNase, showing specific binding and in vitro cytotoxicity on CD30+ lymphoma cells at nM concentrations.